Economic evaluation of health care interventions is becoming increasingly i
mportant as the demand for services increases. For unexplained infertility,
in-vitro fertilization is not a cost-effective first-line treatment option
compared with ovarian stimulation and intrauterine insemination. In clomip
hene citrate-resistant polycystic ovarian syndrome, in-vitro fertilization
may be cost-effective. 2000 Lippincott Williams & Wilkins.